
Cellective AI develops AI-driven cellular therapies to treat cancer and advance regenerative medicine. It uses artificial intelligence and bioengineering to optimize cell training and personalize treatments. The company operates in biotech and AI, targeting medical institutions and biotech partners with cell-based therapies. Category is B2B biotech/healthcare; core tech includes AI, bioengineering, cellular therapy, and precision oncology. The approach aims to scale personalized cancer therapies and expand adoption across clinical settings.

Cellective AI develops AI-driven cellular therapies to treat cancer and advance regenerative medicine. It uses artificial intelligence and bioengineering to optimize cell training and personalize treatments. The company operates in biotech and AI, targeting medical institutions and biotech partners with cell-based therapies. Category is B2B biotech/healthcare; core tech includes AI, bioengineering, cellular therapy, and precision oncology. The approach aims to scale personalized cancer therapies and expand adoption across clinical settings.